John Bermingham serves as the Director of Legal Affairs at Avadel Pharmaceuticals plc, where he leverages nearly two decades of experience in the pharmaceutical industry to navigate complex legal landscapes. With a robust background as Global In-House Counsel, John specializes in contract management and has...
John Bermingham serves as the Director of Legal Affairs at Avadel Pharmaceuticals plc, where he leverages nearly two decades of experience in the pharmaceutical industry to navigate complex legal landscapes. With a robust background as Global In-House Counsel, John specializes in contract management and has honed his expertise in drafting and negotiating a wide array of agreements, including supplier, sales, distribution, and licensing agreements. His comprehensive understanding of FDA regulations and corporate business law enables him to effectively handle transactional matters, employment issues, and compliance with critical legislation such as the Anti-kickback Statute, the Foreign Corrupt Practices Act (FCPA), and the False Claims Act.
At Avadel, John leads initiatives on litigation and settlement agreements, ensuring that the company’s interests are protected while fostering a collaborative approach to dispute resolution. He plays a pivotal role in advising on promotional and non-promotional materials, ensuring compliance with the Sunshine Act and other regulatory requirements. His strategic oversight extends to drafting complex documents such as Asset Purchase Agreements and Specialty Pharmacy Agreements, which are essential for the company’s growth and operational efficiency.
John's skill set encompasses project management, legal compliance, and business process improvement, making him a key player in Avadel’s strategic initiatives. His leadership in these areas not only enhances the company’s legal framework but also supports its mission to deliver innovative pharmaceutical solutions. With a keen eye for data analysis and policy development, John continues to drive Avadel’s commitment to excellence in the life sciences sector, positioning the company for sustained success in a competitive market.
